TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value: $1.18B (100.0% shares, 0.0% debt)

Holdings (36)

CGON CG ONCOLOGY, INC. 11.7%
Value $138M Shares 3,670,206 Est. Cost $40.67 Unrealized -13.8%
DYN DYNE THERAPEUTICS, INC 8.1%
Value $95.19M Shares 2,650,150 Est. Cost $16.62 Unrealized +139.5%
COGT COGENT BIOSCIENCES INC 6.4%
Value $75.22M Shares 6,964,375 Est. Cost $9.05 Unrealized +7.6%
ABVX Abivax SA 5.9%
Value $69.77M Shares 6,056,596 Est. Cost $12.76 Unrealized
EWTX EDGEWISE THERAPEUTICS, INC. 4.8%
Value $56.4M Shares 2,112,984 Est. Cost $15.89 Unrealized +25.2%
SLN SILENCE THERAPEUTICS PLC 4.7%
Value $55.15M Shares 3,033,560 Est. Cost $14.21 Unrealized
SVRA SAVARA INC. 4.4%
Value $52.42M Shares 12,362,205 Est. Cost $3.73 Unrealized +18.3%
KROS KEROS THERAPEUTICS, INC. 4.3%
Value $51.06M Shares 879,344 Est. Cost $59.30 Unrealized -16.7%
XNCR XENCOR INC 4.1%
Value $48.81M Shares 2,427,138 Est. Cost $18.77 Unrealized 0.0%
TYRA TYRA BIOSCIENCES INC 4.0%
Value $46.76M Shares 1,989,103 Est. Cost $12.71 Unrealized +65.2%
GPCR STRUCTURE THERAPEUTICS INC 4.0%
Value $46.66M Shares 1,063,000 Est. Cost $43.45 Unrealized
OCUL OCULAR THERAPEUTIX, INC. 3.9%
Value $46.28M Shares 5,319,148 Est. Cost $7.10 Unrealized +16.1%
CNTA CENTESSA PHARMACEUTICALS PLC 3.9%
Value $46.22M Shares 2,890,816 Est. Cost $7.22 Unrealized
TOURMALINE BIO INC 3.2%
Value $37.99M Shares 1,477,593 Est. Cost $25.14 Unrealized
THIRD HARMONIC BIO INC 2.8%
Value $32.72M Shares 2,415,000 Est. Cost $13.55 Unrealized
ASTRIA THERAPEUTICS, INC. 2.6%
Value $30.41M Shares 2,761,861 Est. Cost $14.07 Unrealized
MLYS MINERALYS THERAPEUTICS, INC. 2.5%
Value $29.91M Shares 2,470,265 Est. Cost $12.35 Unrealized -2.0%
KURA KURA ONCOLOGY INC 2.4%
Value $27.82M Shares 1,423,642 Est. Cost $14.54 Unrealized +39.3%
SLNO SOLENO THERAPEUTIVS, INC. 2.4%
Value $27.77M Shares 550,000 Est. Cost $47.87 Unrealized 0.0%
CMPS COMPASS PATHWAYS PLC 2.1%
Value $24.31M Shares 3,858,000 Est. Cost $7.40 Unrealized
IRON Disc Medicine, Inc. 2.0%
Value $23.93M Shares 486,957 Est. Cost $33.98 Unrealized +38.2%
FULC FULCRUM THERAPEUTICS INC 1.6%
Value $18.74M Shares 5,250,000 Est. Cost $7.42 Unrealized 0.0%
MBX MBX BIOSCIENCES INC 1.4%
Value $16.89M Shares 650,000 Est. Cost $22.87 Unrealized 0.0%
AMLX AMYLYX PHARMACEUTICALS INC 1.3%
Value $15.05M Shares 4,643,812 Est. Cost $2.25 Unrealized 0.0%
ADVERUM BIOTECHNOLOGIES, INC. 1.2%
Value $14.1M Shares 2,008,339 Est. Cost $7.02 Unrealized
TRDA ENTRADA THERAPEUTICS INC 0.8%
Value $9.348M Shares 584,955 Est. Cost $17.12 Unrealized
VTGN VISTAGEN THERAPEUTICS INC 0.7%
Value $8.057M Shares 2,676,580 Est. Cost $3.41 Unrealized 0.0%
TARS TARSUS PHARMACEUTICALS, INC. 0.6%
Value $7.625M Shares 231,820 Est. Cost $17.70 Unrealized +58.8%
EYPT EyePoint Pharmaceuticals, Inc. 0.6%
Value $7.369M Shares 922,335 Est. Cost $13.97 Unrealized -37.1%
NEKTAR THERAPEUTICS 0.4%
Value $5.2M Shares 4,000,000 Est. Cost $0.93 Unrealized
AEROVATE THERAPEUTICS INC 0.4%
Value $4.683M Shares 2,240,809 Est. Cost $15.50 Unrealized
AVTX AVALO THERAPEUTICS INC 0.4%
Value $4.588M Shares 483,000 Est. Cost $10.31 Unrealized 0.0%
KOD KODIAK SCIENCES INC 0.2%
Value $2.631M Shares 1,008,158 Est. Cost $3.95 Unrealized -32.7%
ANTX AN2 Therapeutics, Inc. 0.1%
Value $1.664M Shares 1,555,118 Est. Cost $9.33 Unrealized -81.4%
VTYX VENTYX BIOSCIENCES, INC 0.1%
Value $689K Shares 316,195 Est. Cost $29.94 Unrealized -92.3%
CABA CABALETTA BIO, INC 0.0%
Value $410K Shares 86,795 Est. Cost $3.64 Unrealized +58.9%